ACM Research, Inc. (ACMR): who owns it and who trades it
As of Nov 16, 2026, ACMR insiders reported 70 open-market sales worth $50.2M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was David H Wang (Director), with $29M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling ACM Research
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ACMR
373 funds and institutions reported ACMR shares worth $6.2B at the end of Q2 2026. The largest holder is BlackRock, Inc. with $1.1B.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 8.66M | – | $1.1B | +8% |
| Vanguard Portfolio Management LLC | 3.35M | – | $425M | +52% |
| Vanguard Capital Management LLC | 2.46M | – | $312M | +9% |
| Capital World Investors | 2.40M | – | $304M | – |
| State Street Corp | 2.19M | – | $278M | +9% |
| Geode Capital Management, LLC | 1.49M | – | $189M | +9% |
| Invesco Ltd. | 1.17M | – | $148M | +49% |
| Value Aligned Research Advisors, LLC | 1.05M | – | $134M | +10% |
| WFM ASIA (BVI) Ltd | 969,200 | – | $123M | – |
| Dimensional Fund Advisors LP | 954,474 | – | $121M | +33% |
| Wcm Investment Management, LLC | 917,651 | – | $109M | -51% |
| Polunin Capital Partners Ltd | 748,498 | – | $77.1M | -2% |
| Tekne Capital Management, LLC | 737,500 | – | $93.6M | +3% |
| Morgan Stanley | 700,185 | – | $88.8M | -41% |
| FMR LLC (Fidelity) | 672,184 | – | $85.3M | +7% |
| Fuller & Thaler Asset Management, Inc. | 639,448 | – | $81.1M | – |
| Gilder Gagnon Howe & Co LLC | 637,058 | – | $80.8M | +794% |
| Citadel Advisors LLC | 636,836 | – | $80.8M | +213% |
| Capital International Investors | 623,429 | – | $79.1M | – |
| T. Rowe Price Associates | 591,573 | – | $75.1M | +173% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ACMR insiders reported $0 of open-market purchases and $50.2M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | David H Wang | Director | Sale | 4,807 | $76.73 | $369K | Form 4 |
| Sep 9, 2026 | David H Wang | Director | Sale | 1,100 | $77.59 | $85.3K | Form 4 |
| Sep 9, 2026 | David H Wang | Director | Sale | 11,666 | $75.58 | $882K | Form 4 |
| Sep 9, 2026 | David H Wang | Director | Sale | 18,934 | $74.67 | $1.4M | Form 4 |
| Sep 9, 2026 | David H Wang | Director | Sale | 33,493 | $73.80 | $2.5M | Form 4 |
| Sep 8, 2026 | David H Wang | Director | Sale | 1,500 | $78.57 | $118K | Form 4 |
| Sep 8, 2026 | David H Wang | Director | Sale | 12,323 | $78.08 | $962K | Form 4 |
| Sep 8, 2026 | David H Wang | Director | Sale | 51,374 | $77.15 | $4M | Form 4 |
| Sep 8, 2026 | David H Wang | Director | Sale | 4,803 | $75.99 | $365K | Form 4 |
| Aug 20, 2026 | Mark McKechnie | See Remarks | Sale | 11,209 | $77.89 | $873K | Form 4 |
| Aug 20, 2026 | Mark McKechnie | See Remarks | Sale | 30,365 | $77.45 | $2.4M | Form 4 |
| Aug 20, 2026 | Mark McKechnie | See Remarks | Sale | 13,625 | $76.34 | $1M | Form 4 |
| Aug 18, 2026 | Haiping Dun | Director | Sale | 3,400 | $81.31 | $276K | Form 4 |
| Aug 18, 2026 | Haiping Dun | Director | Sale | 1,200 | $80.29 | $96.3K | Form 4 |
| Aug 18, 2026 | Haiping Dun | Director | Sale | 400 | $82.17 | $32.9K | Form 4 |
| Jun 5, 2026 | Sotheara Cheav | See remarks | Sale | 400 | $84.01 | $33.6K | Form 4 |
| Jun 5, 2026 | Sotheara Cheav | See remarks | Sale | 2,384 | $81.73 | $195K | Form 4 |
| Jun 5, 2026 | Sotheara Cheav | See remarks | Sale | 968 | $82.61 | $80K | Form 4 |
| Jun 5, 2026 | Sotheara Cheav | See remarks | Sale | 1,647 | $85.41 | $141K | Form 4 |
| Jun 4, 2026 | Sotheara Cheav | See remarks | Sale | 2,839 | $85.77 | $244K | Form 4 |
| Jun 4, 2026 | Sotheara Cheav | See remarks | Sale | 1,300 | $84.08 | $109K | Form 4 |
| Jun 4, 2026 | Sotheara Cheav | See remarks | Sale | 9,212 | $85.11 | $784K | Form 4 |
| Jun 4, 2026 | David H Wang | Director | Sale | 10,992 | $86.07 | $946K | Form 4 |
| Jun 4, 2026 | David H Wang | Director | Sale | 17,543 | $85.11 | $1.5M | Form 4 |
| Jun 4, 2026 | David H Wang | Director | Sale | 2,060 | $83.86 | $173K | Form 4 |
| Jun 4, 2026 | David H Wang | Director | Sale | 8,581 | $87.13 | $748K | Form 4 |
| Jun 4, 2026 | David H Wang | Director | Sale | 826 | $87.91 | $72.6K | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 1,187 | $93.04 | $110K | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 4,300 | $87.57 | $377K | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 6,295 | $88.98 | $560K | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 32,450 | $89.84 | $2.9M | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 9,925 | $90.78 | $901K | Form 4 |
| Jun 3, 2026 | David H Wang | Director | Sale | 5,843 | $92.38 | $540K | Form 4 |
| May 19, 2026 | Haiping Dun | Director | Sale | 500 | $65.09 | $32.5K | Form 4 |
| May 19, 2026 | Haiping Dun | Director | Sale | 1,333 | $63.84 | $85.1K | Form 4 |
| May 19, 2026 | Haiping Dun | Director | Sale | 1,858 | $67.54 | $125K | Form 4 |
| May 19, 2026 | Haiping Dun | Director | Sale | 1,309 | $67.21 | $88K | Form 4 |
| Apr 17, 2026 | Charles C Pappis | Director | Sale | 5,000 | $52.00 | $260K | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 564 | $46.57 | $26.3K | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 29,348 | $45.74 | $1.3M | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 8,639 | $44.94 | $388K | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 982 | $46.55 | $45.7K | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 47,108 | $45.74 | $2.2M | Form 4 |
| Mar 12, 2026 | Mark McKechnie | See Remarks | Sale | 11,910 | $44.89 | $535K | Form 4 |
| Mar 12, 2026 | David H Wang | Director | Sale | 702 | $46.57 | $32.7K | Form 4 |
| Mar 12, 2026 | David H Wang | Director | Sale | 10,561 | $44.92 | $474K | Form 4 |
| Mar 12, 2026 | David H Wang | Director | Sale | 38,737 | $45.74 | $1.8M | Form 4 |
| Mar 11, 2026 | David H Wang | Director | Sale | 55,373 | $47.89 | $2.7M | Form 4 |
| Mar 11, 2026 | David H Wang | Director | Sale | 4,627 | $48.34 | $224K | Form 4 |
| Mar 11, 2026 | Tracy Liu | Director | Sale | 3,377 | $48.25 | $163K | Form 4 |
| Mar 11, 2026 | Tracy Liu | Director | Sale | 11,623 | $47.81 | $556K | Form 4 |
| Mar 10, 2026 | Tracy Liu | Director | Sale | 12,784 | $48.19 | $616K | Form 4 |
| Mar 10, 2026 | Tracy Liu | Director | Sale | 32,216 | $47.06 | $1.5M | Form 4 |
| Mar 9, 2026 | Haiping Dun | Director | Sale | 900 | $43.94 | $39.5K | Form 4 |
| Mar 9, 2026 | Haiping Dun | Director | Sale | 4,100 | $43.37 | $178K | Form 4 |
| Mar 6, 2026 | Lisa Feng | See remarks | Sale | 14,800 | $46.07 | $682K | Form 4 |
| Mar 6, 2026 | Lisa Feng | See remarks | Sale | 200 | $46.58 | $9.3K | Form 4 |
| Mar 5, 2026 | Charles C Pappis | Director | Sale | 5,000 | $50.09 | $250K | Form 4 |
| Mar 5, 2026 | Lisa Feng | See remarks | Sale | 6,950 | $50.24 | $349K | Form 4 |
| Mar 5, 2026 | Lisa Feng | See remarks | Sale | 8,050 | $49.81 | $401K | Form 4 |
| Dec 8, 2025 | Mark McKechnie | See Remarks | Sale | 22,500 | $35.45 | $798K | Form 4 |
| Dec 4, 2025 | Mark McKechnie | See Remarks | Sale | 7,754 | $33.50 | $260K | Form 4 |
| Dec 4, 2025 | Mark McKechnie | See Remarks | Sale | 996 | $34.26 | $34.1K | Form 4 |
| Dec 4, 2025 | David H Wang | Director | Sale | 40,183 | $34.42 | $1.4M | Form 4 |
| Dec 4, 2025 | David H Wang | Director | Sale | 19,817 | $33.52 | $664K | Form 4 |
| Dec 3, 2025 | David H Wang | Director | Sale | 68,800 | $33.05 | $2.3M | Form 4 |
| Dec 3, 2025 | David H Wang | Director | Sale | 1,200 | $33.56 | $40.3K | Form 4 |
| Dec 3, 2025 | Fuping Chen | See remarks | Sale | 19,700 | $33.05 | $651K | Form 4 |
| Dec 3, 2025 | Fuping Chen | See remarks | Sale | 300 | $33.57 | $10.1K | Form 4 |
| Dec 2, 2025 | Fuping Chen | See remarks | Sale | 100,000 | $33.20 | $3.3M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| David H Wang | See Remarks, Director, 10% owner | – | $29M | Sep 9, 2026 |
| Mark McKechnie | See Remarks | – | $9.8M | Aug 20, 2026 |
| Fuping Chen | See remarks | – | $4M | Dec 3, 2025 |
| Tracy Liu | Director | – | $2.9M | Mar 11, 2026 |
| Sotheara Cheav | See remarks | – | $1.6M | Jun 5, 2026 |
| Lisa Feng | See remarks | – | $1.4M | Mar 6, 2026 |
| Haiping Dun | Director | – | $954K | Aug 18, 2026 |
| Charles C Pappis | Director | – | $510K | Apr 17, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ACMR short interest
2.97M ACMR shares are sold short. Over the last 12 reports the number of shares short went up 6%.
As of Oct 30, 2026, 2.97M ACMR shares were sold short, down 14.7% from the report before. At the average daily volume of 1.01M shares, buying them all back would take about 3.0 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.97M | – | -15% | 1.01M | 3.0 |
| Oct 15, 2026 | 3.48M | – | -14% | 1.35M | 2.6 |
| Sep 30, 2026 | 4.06M | – | -2% | 1.29M | 3.2 |
| Sep 15, 2026 | 4.14M | – | +4% | 891,359 | 4.6 |
| Aug 31, 2026 | 3.97M | – | +21% | 909,104 | 4.4 |
| Aug 14, 2026 | 3.29M | – | -9% | 812,081 | 4.0 |
| Jul 31, 2026 | 3.60M | – | -8% | 1.08M | 3.4 |
| Jul 15, 2026 | 3.91M | – | +20% | 1.37M | 2.9 |
| Jun 30, 2026 | 3.25M | – | +38% | 2.12M | 1.5 |
| Jun 15, 2026 | 2.36M | – | -22% | 1.60M | 1.5 |
| May 29, 2026 | 3.01M | – | +8% | 1.94M | 1.6 |
| May 15, 2026 | 2.80M | – | +2% | 1.86M | 1.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
ACM Research company events
ACM Research filed 24 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Nov 3, 2026LeadershipACM Research, Inc. announced that, effective October 1, 2026, Yue Ma had commenced employment with the Company as Chief Operations Officer. Filing
- Oct 28, 2026ResultsReleased financial results. Filing
- Sep 30, 2026AnnouncementWe issued a press release entitled “ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Backlog Data.” The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.. Item 9.01 Financial Statements and Exhibits. Filing
- Aug 27, 2026AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Aug 7, 2026ResultsReleased financial results. Filing
- Jun 22, 2026AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Jun 12, 2026VoteReported shareholder vote results. Filing
- May 29, 2026AnnouncementThe shares of the operating subsidiary of ACM Research, Inc., ACM Research (Shanghai), Inc., are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- May 22, 2026AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- May 15, 2026AnnouncementAs previously disclosed, on May 12, 2026, ACM Research, Inc. entered into a Securities Purchase Agreement with certain investors named therein. Filing
- May 12, 2026AgreementACM Research, Inc. entered into a Securities Purchase Agreement with certain U.S. institutional investors named therein managed by Tekne Capital Management, LLC. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 27, 2026ResultsReleased financial results. Filing
- Apr 17, 2026AnnouncementThe shares of the operating subsidiary of ACM Research, Inc., ACM Research (Shanghai), Inc., are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Mar 24, 2026AnnouncementThe shares of the operating subsidiary of ACM Research, Inc., ACM Research (Shanghai), Inc., are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Mar 19, 2026AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Feb 6, 2026AnnouncementAs previously disclosed, on January 30, 2026, ACM Research (Shanghai), Inc., the operating subsidiary of ACM Research, Inc. issued a notice to the Shanghai Stock Exchange that the Company intends to sell 4,801,648 shares of ACM Shanghai through an inquiry-based share transfer plan. Filing
- Feb 4, 2026AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Feb 3, 2026AnnouncementAs previously disclosed, on January 30, 2026, ACM Research (Shanghai), Inc., the operating subsidiary of ACM Research, Inc. issued a notice to the Shanghai Stock Exchange that the Company intends to sell 4,801,648 shares of ACM Shanghai through an inquiry-based share transfer plan. Filing
- Jan 30, 2026AnnouncementThe shares of the operating subsidiary of ACM Research, Inc., ACM Research (Shanghai), Inc., are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
- Jan 22, 2026ResultsReleased financial results. Filing
- Nov 21, 2025AnnouncementThe shares of our operating subsidiary ACM Research (Shanghai), Inc. are listed on the Sci-Tech innovation board of the Shanghai Stock Exchange. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
ACM Research financials
Famous investors that hold ACMR
4 of the 50 well-known investors we track reported holding ACMR in their latest 13F filing. The largest position is Ken Griffin's, worth $102M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.26M | $102M | 0.1% | +99% |
| Israel Englander · Millennium Management | Q3 2026 | 456,277 | $36.9M | 0.0% | +225% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 124,931 | $10.1M | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 101,700 | $8.2M | 0.0% | -56% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about ACM Research, Inc. (ACMR) stock
Who owns the most ACMR stock?
The largest reported owner of ACM Research, Inc. (ACMR) is BlackRock, Inc.. In total, 373 funds and institutions reported holding ACMR at the end of Q2 2026. See the largest owners.
Are ACMR insiders buying or selling?
In the last 12 months, ACMR insiders reported no open-market purchases and 70 sales worth $50.2M. The latest trade was on Sep 9, 2026. See every trade.
What is the short interest in ACMR?
As of Oct 30, 2026, 2.97M ACMR shares were sold short, down 14.7% from the report before. At the average daily volume of 1.01M shares, buying them all back would take about 3.0 trading days (days to cover). See the history.
Which famous investors hold ACMR?
4 of the 50 well-known investors we track reported ACMR in their latest 13F filing, including Ken Griffin, Israel Englander, Ray Dalio. The largest position is worth $102M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.